Skip to main content
. Author manuscript; available in PMC: 2023 Jul 18.
Published in final edited form as: J Am Board Fam Med. 2023 Apr 7;36(3):501–509. doi: 10.3122/jabfm.2022.220342R1

Table 4.

Preventive Health Services Completion among Eligible Patients by Completion of Annual Wellness Visits (at Baseline and 8 Months Post-Intervention Implementation)

Preventive health service Baseline 8 months post-implementation
Completed AWV, %
(n=107)
Did Not Complete AWV, %
(n=1406)
p-value Completed AWV, %
(n=630)
Did Not Complete AWV, %
(n=537)
p-value
Vaccinations
  Influenza 55.1 55.9 0.249 62.7 56.3 0.036
  Herpes zoster (shingles) 60.0 42.2 < 0.001 53.5 39.9 < 0.001
  Pneumococcal (PPSV23) 85.1 71.2 0.004 83.2 63.4 < 0.001
  Tetanus (Td or Tdap) 74.8 55.7 < 0.001 63.0 49.4 < 0.001
Cancer screening
  Colorectal cancer 22.2 35.1 0.037 37.5 27.7 0.006
  Mammogram 48.8 41.0 0.331 49.5 39.5 0.065
  Pap smear 100.0 54.0 0.113 77.4 50.0 0.014
  PSA (prostate) 71.4 63.4 0.542 74.7 35.2 < 0.001
Other screening
  Osteoporosis 36.0 38.0 0.843 54.5 33.6 0.001
  Hepatitis C 24.1 23.3 0.852 37.1 20.2 < 0.001
  Alcohol misuse screening 90.7 38.8 < 0.001 91.4 23.0 < 0.001
  Depression screening 93.9 48.2 < 0.001 97.5 33.8 < 0.001
  Tobacco use screening 89.7 84.1 0.122 86.4 71.9 < 0.001
Advance care planning 10.1 7.7 0.388 27.4 7.5 < 0.001
Fulfillment of recommended preventive health services * 61.5 46.4 < 0.001 65.7 39.7 < 0.001
*

% fulfillment of all recommended preventive health services listed in this table computed at the patient level [except for tetanus vaccination (since Medicare Part B does not routinely cover it) and PSA screening (a measure of overuse)] (maximum of n=12 services)